Top 5 Growth Stocks in Biotech

4. Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT)

Revenue Growth YOY: 485.03%

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) is a messenger RNA (mRNA) medicines company based in the United States. The company focuses on the development of therapeutics for infectious diseases and liver and rare respiratory disorders. The product pipeline of Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) comprises LUNAR®-GSDIII for the treatment of glycogen storage disease (GSD) type III, a COVID-19 vaccine candidate LUNAR®-COV19, and LUNAR®-FLU for the treatment of seasonal and pandemic influenza.

According to Insider Monkey’s database, 9 hedge funds held stakes worth $73 million in Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) in Q4 2022, compared to 10 funds in the prior quarter with stakes worth $67 million.